Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) has been given an average recommendation of “Moderate Buy” by the seven ratings firms that are currently covering the company, Marketbeat.com reports. Three research analysts have rated the stock with a hold recommendation, three have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target price among analysts that have covered the stock in the last year is $45.33.
Several research analysts have issued reports on the stock. Bank of America increased their target price on shares of Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a report on Friday, September 20th. Stifel Nicolaus lifted their price objective on shares of Trupanion from $42.00 to $44.00 and gave the company a “hold” rating in a report on Monday, January 6th. Piper Sandler upped their target price on Trupanion from $45.00 to $57.00 and gave the stock a “neutral” rating in a report on Thursday, October 31st. Finally, Northland Securities lifted their price target on Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a report on Thursday, October 31st.
Check Out Our Latest Analysis on TRUP
Trupanion Stock Performance
Trupanion (NASDAQ:TRUP – Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $0.03 EPS for the quarter, topping the consensus estimate of ($0.06) by $0.09. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. The company had revenue of $327.50 million for the quarter, compared to the consensus estimate of $321.79 million. During the same period last year, the business posted ($0.10) EPS. Trupanion’s quarterly revenue was up 14.6% on a year-over-year basis. As a group, equities analysts predict that Trupanion will post -0.23 EPS for the current year.
Insider Activity
In other Trupanion news, CFO Fawwad Qureshi sold 622 shares of the company’s stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $52.61, for a total transaction of $32,723.42. Following the transaction, the chief financial officer now owns 9,867 shares in the company, valued at approximately $519,102.87. This represents a 5.93 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Murray B. Low sold 2,000 shares of the firm’s stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $52.67, for a total transaction of $105,340.00. Following the completion of the transaction, the director now directly owns 131,513 shares of the company’s stock, valued at approximately $6,926,789.71. This represents a 1.50 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 28,597 shares of company stock worth $1,522,082. Insiders own 5.50% of the company’s stock.
Institutional Trading of Trupanion
A number of institutional investors and hedge funds have recently added to or reduced their stakes in TRUP. Quest Partners LLC purchased a new stake in shares of Trupanion in the 3rd quarter valued at $37,000. Wilmington Savings Fund Society FSB purchased a new stake in Trupanion in the third quarter valued at $54,000. GAMMA Investing LLC boosted its holdings in Trupanion by 70.4% in the third quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider’s stock valued at $61,000 after purchasing an additional 596 shares during the last quarter. Headlands Technologies LLC acquired a new stake in Trupanion during the 2nd quarter worth about $162,000. Finally, Entropy Technologies LP purchased a new position in shares of Trupanion during the 3rd quarter valued at about $202,000.
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Read More
- Five stocks we like better than Trupanion
- Short Selling: How to Short a Stock
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- What Are Some of the Best Large-Cap Stocks to Buy?
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- Following Congress Stock Trades
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.